0001062993-24-005986.txt : 20240308
0001062993-24-005986.hdr.sgml : 20240308
20240308163052
ACCESSION NUMBER: 0001062993-24-005986
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grant Richard N. Jr.
CENTRAL INDEX KEY: 0001821315
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36117
FILM NUMBER: 24734886
MAIL ADDRESS:
STREET 1: C/O INTEST CORP
STREET 2: 804 EAST GATE DR, SUITE 200
CITY: MT. LAUREL
STATE: NJ
ZIP: 08054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEST CORP
CENTRAL INDEX KEY: 0001036262
STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 222370659
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 804 EAST GATE DR., SUITE 200
CITY: MT. LAUREL
STATE: NJ
ZIP: 08054
BUSINESS PHONE: 856-505-8800
MAIL ADDRESS:
STREET 1: 804 EAST GATE DR., SUITE 200
CITY: MT. LAUREL
STATE: NJ
ZIP: 08054
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-03-06
0001036262
INTEST CORP
INTT
0001821315
Grant Richard N. Jr.
C/O INTEST CORP
804 EAST GATE DR, SUITE 200
MT. LAUREL
NJ
08054
1
1
0
0
President & CEO
0
Common Stock
2024-03-06
4
A
0
17652
0
A
220203
D
Common Stock
2024-03-06
4
A
0
17652
0
A
237855
D
Employee Stock Option (right to buy)
11.33
2024-03-06
4
A
0
30536
0
A
2034-03-05
Common Stock
30536
30536
D
Employee Stock Option (right to buy)
16.06
2033-03-07
Common Stock
16988
16988
D
Employee Stock Option (right to buy)
9.76
2032-03-08
Common Stock
25692
25692
D
Employee Stock Option (right to buy)
10.62
2031-03-09
Common Stock
112000
112000
D
These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025.
These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 6, 2027 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 26,478.
This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025.
This option vests in four equal annual installments commencing on March 8, 2024.
This option vests in four equal annual installments commencing on March 9, 2023.
This option vests in four equal annual installments commencing on March 10, 2022.
/s/ Richard N. Grant, Jr.
2024-03-08